BIO-TECHNE Corp
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Director
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Director
Common Stock
Director
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP - General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP - General Counsel
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CFO
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CFO
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
PRESIDENT, PROTEIN SCIENCES
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
PRESIDENT, PROTEIN SCIENCES
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President - Diag & Spatial Bi
Restricted Stock Units
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Executive Officer
Common Stock
Chief Executive Officer
Performance Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockOption exercise or conversion | 15,940$0 reported · see filing | Not established | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockExercise-price or tax withholding | 5,562$72.51 / share | $403.3K | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Stock Options (Right to Buy)Option exercise or conversion | Derivative units15,940$25.30 exercise / conversion price | Not a separate purchase | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 15,940$0 reported · see filing | Not established | Sep 22Filed Sep 24 · 2d later | SEC filing |
| Director | Common StockExercise-price or tax withholding | 5,559$72.55 / share | $403.31K | Sep 22Filed Sep 24 · 2d later | SEC filing |
| Director | Stock Options (Right to Buy)Option exercise or conversion | Derivative units15,940$25.30 exercise / conversion price | Not a separate purchase | Sep 22Filed Sep 24 · 2d later | SEC filing |
| SVP - General Counsel | Restricted Stock UnitsGrant or award | Derivative units11,344Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| SVP - General Counsel | Restricted Stock UnitsGrant or award | Derivative units18,432Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsGrant or award | Derivative units57,590Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsGrant or award | Derivative units93,582Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| CFO | Restricted Stock UnitsGrant or award | Derivative units22,438Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| CFO | Restricted Stock UnitsGrant or award | Derivative units36,459Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Director | Restricted Stock UnitsGrant or award | Derivative units1,381Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Restricted Stock UnitsGrant or award | Derivative units14,762Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| PRESIDENT, PROTEIN SCIENCES | Restricted Stock UnitsGrant or award | Derivative units23,985Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsGrant or award | Derivative units8,702Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| President - Diag & Spatial Bi | Restricted Stock UnitsGrant or award | Derivative units14,140Award · no purchase price | Non-cash award | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 21,470$0 reported · see filing | Not established | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding | 10,821$72.40 / share | $783.44K | Aug 15Filed Aug 18 · 3d later | SEC filing |
| Chief Executive Officer | Performance Restricted Stock UnitsOption exercise or conversion | Derivative units554Exercise / conversion price not reported | Not a separate purchase | Aug 15Filed Aug 18 · 3d later | SEC filing |
Showing the latest 20 of 98 trades. Show all 98 trades
Bio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a sale for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberBio-Techne Corp - Common Stock (TECH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House member